Axon Enterprise, Inc. (NASDAQ:AXON) President Joshua Isner Sells 25,811 Shares of Stock

Axon Enterprise, Inc. (NASDAQ:AXONGet Free Report) President Joshua Isner sold 25,811 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the sale, the president now directly owns 228,166 shares of the company’s stock, valued at $82,103,253.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $359.35 on Wednesday. The business’s 50 day simple moving average is $334.23 and its 200 day simple moving average is $312.76. Axon Enterprise, Inc. has a 12 month low of $189.12 and a 12 month high of $378.89. The company has a market cap of $27.16 billion, a price-to-earnings ratio of 105.07, a PEG ratio of 9.50 and a beta of 0.94. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the company earned $0.80 EPS. The firm’s quarterly revenue was up 34.5% compared to the same quarter last year. Sell-side analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on AXON. Craig Hallum increased their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Bank of America initiated coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective on the stock. Barclays lifted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Jefferies Financial Group started coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price for the company. Finally, Northland Securities boosted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $361.15.

Check Out Our Latest Stock Report on Axon Enterprise

Hedge Funds Weigh In On Axon Enterprise

Large investors have recently modified their holdings of the business. Blue Trust Inc. boosted its holdings in Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the period. ICA Group Wealth Management LLC purchased a new position in shares of Axon Enterprise in the fourth quarter valued at $26,000. Trivant Custom Portfolio Group LLC bought a new stake in shares of Axon Enterprise during the 1st quarter valued at $31,000. First PREMIER Bank purchased a new stake in Axon Enterprise during the 1st quarter worth about $33,000. Finally, Blue Bell Private Wealth Management LLC bought a new position in Axon Enterprise in the 1st quarter worth about $41,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Insider Buying and Selling by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.